|Bid||7.20 x 3200|
|Ask||7.23 x 4000|
|Day's range||6.95 - 7.34|
|52-week range||3.71 - 18.98|
|Beta (5Y monthly)||3.12|
|PE ratio (TTM)||N/A|
|Earnings date||20 Sep 2021 - 24 Sep 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Tilray CEO Irwin Simon talks with Yahoo Finance's Julie Hyman on the integration of Tilray and Aphria thus far, and his vision for the company and cannabis industry heading into a post-pandemic world.
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Theresa Firestone to the Company's Board of Directors (the "Board"), effective today. This is a newly created directorship that expands the Board to nine members, seven of whom are independent.
This year has already brought us some big acquisitions, both in Canada and in the U.S. Perhaps the biggest was the merging of two Canadian players, Aphria and Tilray, to create the "new" Tilray, which was completed in May. The recent acquisition of Harvest Health & Recreation by Florida-based Trulieve Cannabis was also a highlight. Canadian player Aurora Cannabis (NASDAQ: ACB) has been on a roller-coaster ride since 2020, while fellow Canadian company Canopy Growth (NASDAQ: CGC) has held its ground. Let's take a look at their progress this year and determine which of these two pot stocks is the better buy now.